2020 MDA Clinical & Scientific Conference Accreditation and Designation Statements


This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of PeerPoint Medical Education Institute, LLC and Muscular Dystrophy Association.The PeerPoint Medical Education Institute, LLC is accredited by the ACCME to provide continuing medical education for physicians.

The PeerPoint Medical Education Institute, LLC designates this Enduring Material activity for a maximum of 22 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Sources of Funding

No educational grants or in-kind CME support from commercial interests was received for this activity.

At the conclusion of this CME activity, attendees should be better prepared to:

  1. Identify and apply diagnostic approaches in neuromuscular disease
  2. Adopt the latest strategies and findings in core approaches to medical management of neuromuscular diseases — including cardiac and respiratory care, physical and occupational therapy and addressing psychosocial needs
  3. Assess and appraise the clinical trial landscape in order to educate families about clinical trial opportunities for which they may be eligible
  4. Recognize and use medical best practices in a multidisciplinary environment to help improve medical outcomes and patient satisfaction